Issue link: https://www.e-digitaleditions.com/i/1521797
Inhalation June 2024 17 Transl Res, vol. 12, no. 4, 2022, doi: 10.1007/ s13346-020-00891-5. 7. M. Gomez and R. Vehring, Spray drying and par- ticle engineering in dosage form design for global vaccines, J Aerosol Med Pulm Drug Deliv, vol. 35, no. 3, 2022, doi: 10.1089/jamp.2021.0056. 8. R. Nakahashi-Ouchida, K. Fujihashi, Y. Kurashima, Y. Yuki and H. Kiyono, Nasal vaccines: Solutions for respiratory infectious diseases, Trends Mol Med, vol. 29, no. 2, pp. 124-140, Feb. 2023, doi: 10.1016/j.molmed.2022.10.009. 9. F. Sonvico, G. Colombo, E. Quarta, F. Guares- chi, S. Banella, F. Buttini and R. Scherließ, Nasal delivery as a strategy for the prevention and treat- ment of COVID-19, Expert Opin Drug Deliv, vol. 20, no. 8, pp. 1115-1130, Aug. 2023, doi: 10.1080/17425247.2023.2263363. 10. B. J. Mann, TaffiX ® nasal powder forms an effective barrier against SARS-CoV-2, Biomed J Sci Tech Res, vol. 33, no. 3, 2021, doi: 10.26717/ bjstr.2021.33.005405. 11. D. Hull, P. Rennie, A. Noronha, C. Poore, N. Harrington, V. Fearnley and D. Passàli, Effects of creating a non-specific, virus-hostile environment in the nasopharynx on symptoms and duration of com- mon cold, Acta Otorhinolaryngol Ital, vol. 27, no. 2, 2007, PMCID: PMC2640010. References 1. L. T. Fasiolo, M. D. Manniello, E. Tratta, F. Butt- ini, A. Rossi, F. Sonvico, F. Bortolotti, R. Russo and G. Colombo, Opportunity and challenges of nasal powders: Drug formulation and delivery, Eur J Pharm Sci, vol. 113, 2018, doi: 10.1016/j.ejps.2017.09.027. 2. R. Scherließ, Nasal formulations for drug admin- istration and characterization of nasal preparations in drug delivery, er Deliv, vol. 11, no. 3, pp. 183- 191, Mar. 2020, doi: 10.4155/tde-2019-0086. 3. W. Alabsi, B. B. Eedara, D. Encinas-Basurto, R. Polt and H. M. Mansour, Nose-to-brain deliv- ery of therapeutic peptides as nasal aerosols, Phar- maceutics, vol. 14, no. 9, 2022, doi: 10.3390/ pharmaceutics14091870. 4. J. Tai, M. Han, D. Lee, I. H. Park, S. H. Lee and T. H. Kim, Different methods and formula- tions of drugs and vaccines for nasal administration, Pharmaceutics, vol. 14, no. 5, 2022, doi: 10.3390/ pharmaceutics14051073. 5. G. Williams, J. Suman and D. Marx, e poten- tial of dry powder vaccines for intranasal immuniza- tion, CTVV, vol. 4, no. 1, Feb. 2021, doi: 10.31021/ CTVV.20214115. 6. L. A. Keller, O. Merkel and A. Popp, Intrana- sal drug delivery: Opportunities and toxicologic challenges during drug development, Drug Deliv